{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:01:35Z","timestamp":1792213295314,"version":"4.4.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.cca.2022.02.002","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T12:23:37Z","timestamp":1644236617000},"page":"46-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Copeptin in fluid disorders and stress"],"prefix":"10.1016","volume":"529","author":[{"given":"Danni","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11154-019-09509-9","article-title":"Vasopressin and Copeptin in health and disease","volume":"20","author":"Christ-Crain","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/0885066604265246","article-title":"Vasopressin: applications in clinical practice","volume":"19","author":"Dyke","year":"2004","journal-title":"J Intensive Care Med"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0015","first-page":"368","article-title":"The use of vasopressin assays in physiology and pathophysiology","volume":"14","author":"Robertson","year":"1994","journal-title":"Semin Nephrol"},{"issue":"11","key":"10.1016\/j.cca.2022.02.002_b0020","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1210\/jc.2005-2830","article-title":"Copeptin and arginine vasopressin concentrations in critically ill patients","volume":"91","author":"Jochberger","year":"2006","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"9","key":"10.1016\/j.cca.2022.02.002_b0025","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","article-title":"Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma","volume":"52","author":"Robertson","year":"1973","journal-title":"J Clin Invest"},{"issue":"2 Pt 2","key":"10.1016\/j.cca.2022.02.002_b0030","first-page":"I129","article-title":"Plasma and platelet vasopressin in essential hypertension and congestive heart failure","volume":"5","author":"Preibisz","year":"1983","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09537109777492","article-title":"Vasopressin and platelets: a concise review","volume":"8","author":"Wun","year":"1997","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1432-1033.1972.tb01918.x","article-title":"A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization","volume":"28","author":"Holwerda","year":"1972","journal-title":"Eur J Biochem"},{"issue":"2","key":"10.1016\/j.cca.2022.02.002_b0045","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0006-291X(81)80258-6","article-title":"The complete sequence of a novel human pituitary glycopeptide homologous to pig posterior pituitary glycopeptide","volume":"100","author":"Seidah","year":"1981","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.cca.2022.02.002_b0050","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.peptides.2005.04.019","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients","volume":"26","author":"Struck","year":"2005","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"issue":"5847","key":"10.1016\/j.cca.2022.02.002_b0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/295299a0","article-title":"Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor","volume":"295","author":"Land","year":"1982","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0065","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1399-3011.1986.tb01827.x","article-title":"Ontogeny of bovine neurohypophysial hormone precursors. II. Foetal copeptin, the third domain of the vasopressin precursor","volume":"27","author":"Levy","year":"1986","journal-title":"Int J Pept Protein Res"},{"issue":"5906","key":"10.1016\/j.cca.2022.02.002_b0070","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/302342a0","article-title":"Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA","volume":"302","author":"Land","year":"1983","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cca.2022.02.002_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01534707","article-title":"Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor","volume":"11","author":"Riddell","year":"1985","journal-title":"Somat Cell Mol Genet"},{"key":"10.1016\/j.cca.2022.02.002_b0080","first-page":"S20","article-title":"Physiology of ADH secretion","volume":"21","author":"Robertson","year":"1987","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/endo-75-6-943","article-title":"Evidence for a precursor in vasopressin biosynthesis","volume":"75","author":"Sachs","year":"1964","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2022.02.002_b0090","first-page":"447","article-title":"Biosynthesis and release of vasopressin and neurophysin","volume":"25","author":"Sachs","year":"1969","journal-title":"Recent Prog Horm Res"},{"issue":"2","key":"10.1016\/j.cca.2022.02.002_b0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00218970","article-title":"Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretroy system of the rat","volume":"164","author":"Vandesande","year":"1975","journal-title":"Cell Tissue Res"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0100","first-page":"F321","article-title":"Osmotic and nonosmotic control of vasopressin release","volume":"236","author":"Schrier","year":"1979","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/JMN:18:3:223","article-title":"Dynamic processing of neuropeptides: sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport","volume":"18","author":"Acher","year":"2002","journal-title":"J Mol Neurosci"},{"issue":"5932","key":"10.1016\/j.cca.2022.02.002_b0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/305325a0","article-title":"Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin","volume":"305","author":"Rivier","year":"1983","journal-title":"Nature"},{"issue":"5703","key":"10.1016\/j.cca.2022.02.002_b0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/278463a0","article-title":"Corticotrophin releasing factor may be modulated vasopressin","volume":"278","author":"Gillies","year":"1979","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cca.2022.02.002_b0120","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1043-2760(00)00304-0","article-title":"Vasopressin receptors","volume":"11","author":"Birnbaumer","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.cca.2022.02.002_b0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0079-6123(08)64405-2","article-title":"Vasopressin: mechanisms of receptor activation","volume":"60","author":"Jard","year":"1983","journal-title":"Prog Brain Res"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/00003495-200767060-00002","article-title":"Therapeutic potential of vasopressin receptor antagonists","volume":"67","author":"Ali","year":"2007","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0135","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1210\/endo.133.4.8404628","article-title":"Expression of vasopressin V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, and adult rats","volume":"133","author":"Ostrowski","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2022.02.002_b0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/bs.vh.2019.08.013","article-title":"Vasopressin receptor subtypes and renal sodium transport","volume":"113","author":"Natochin","year":"2020","journal-title":"Vitam Horm"},{"issue":"5155","key":"10.1016\/j.cca.2022.02.002_b0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.8140421","article-title":"Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine","volume":"264","author":"Deen","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cca.2022.02.002_b0150","first-page":"277","article-title":"Renal aquaporins and water balance disorders, Best practice & research","volume":"30","author":"Moeller","year":"2016","journal-title":"Clinical endocrinology & metabolism"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0155","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.151.4.919","article-title":"The subcellular localization of an aquaporin-2 tetramer depends on the stoichiometry of phosphorylated and nonphosphorylated monomers","volume":"151","author":"Kamsteeg","year":"2000","journal-title":"J Cell Biol"},{"issue":"10","key":"10.1016\/j.cca.2022.02.002_b0160","doi-asserted-by":"crossref","first-page":"908","DOI":"10.33963\/KP.14986","article-title":"The role of arginine vasopressin in myocardial infarction and reperfusion","volume":"77","author":"Nobian","year":"2019","journal-title":"Kardiologia polska"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejim.2006.11.008","article-title":"Plasma arginine vasopressin and atrial natriuretic peptide concentration in patients with hyponatremia at diagnosis and following treatment","volume":"18","author":"Coenraad","year":"2007","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0170","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0889-8529(05)70207-3","article-title":"Antidiuretic hormone. Normal and disordered function","volume":"30","author":"Robertson","year":"2001","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"14","key":"10.1016\/j.cca.2022.02.002_b0175","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMra1404726","article-title":"Molecular physiology of water balance","volume":"372","author":"Ingelfinger","year":"2015","journal-title":"The New England journal of medicine"},{"issue":"2","key":"10.1016\/j.cca.2022.02.002_b0180","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1210\/jc.2017-01891","article-title":"Release and Decay Kinetics of Copeptin vs AVP in Response to Osmotic Alterations in Healthy Volunteers","volume":"103","author":"Fenske","year":"2018","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0185","doi-asserted-by":"crossref","first-page":"10104","DOI":"10.1038\/s41598-021-89505-9","article-title":"Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome","volume":"11","author":"Sailer","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cca.2022.02.002_b0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2018.09.005","article-title":"Immunoluminometric assay for copeptin measurement in cerebrospinal fluid: Technical aspects and pilot study","volume":"490","author":"Mindt","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0195","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1210\/jc.2010-2499","article-title":"Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States","volume":"96","author":"Balanescu","year":"2011","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"12","key":"10.1016\/j.cca.2022.02.002_b0200","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1210\/jc.2014-2295","article-title":"Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease","volume":"99","author":"Roussel","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0205","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20080140","article-title":"Gender and renal function influence plasma levels of copeptin in healthy individuals","volume":"116","author":"Bhandari","year":"2009","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0210","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/cen.13583","article-title":"Copeptin role in polyuria-polydipsia syndrome differential diagnosis and reference range in paediatric age","volume":"88","author":"Tuli","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2022.02.002_b0215","doi-asserted-by":"crossref","first-page":"4737082","DOI":"10.1155\/2017\/4737082","article-title":"The Circadian Rhythm of Copeptin, the C-Terminal Portion of Arginine Vasopressin","volume":"2017","author":"Beglinger","year":"2017","journal-title":"J Biomark"},{"issue":"7","key":"10.1016\/j.cca.2022.02.002_b0220","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/1354750X.2014.940504","article-title":"Copeptin levels are independent of ingested nutrient type after standardised meal administration\u2013the CoMEAL study","volume":"19","author":"Walti","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.cca.2022.02.002_b0225","article-title":"Diabetes insipidus and syndrome of inappropriate antidiuretic hormone secretion (SIADH)","volume":"27","author":"Moses","year":"1982","journal-title":"Adv Intern Med"},{"issue":"2","key":"10.1016\/j.cca.2022.02.002_b0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beem.2016.02.003","article-title":"Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia","volume":"30","author":"Christ-Crain","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.cca.2022.02.002_b0235","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1210\/jc.2012-1981","article-title":"Clinical review: Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review","volume":"97","author":"Fenske","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0240","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0889-8529(18)30031-8","article-title":"Diabetes insipidus","volume":"24","author":"Robertson","year":"1995","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"10","key":"10.1016\/j.cca.2022.02.002_b0245","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrneph.2015.89","article-title":"Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus","volume":"11","author":"Bockenhauer","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2022.02.002_b0250","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-73-5-721","article-title":"Recognition of partial defects in antidiuretic hormone secretion","volume":"73","author":"Miller","year":"1970","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.cca.2022.02.002_b0255","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1210\/jc.2010-2345","article-title":"Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome\u2013revisiting the direct and indirect water deprivation tests","volume":"96","author":"Fenske","year":"2011","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0260","doi-asserted-by":"crossref","first-page":"F155","DOI":"10.1152\/ajprenal.00272.2002","article-title":"Altered expression of major renal Na transporters in rats with unilateral ureteral obstruction","volume":"284","author":"Li","year":"2003","journal-title":"American journal of physiology. Renal physiology"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0265","doi-asserted-by":"crossref","first-page":"F163","DOI":"10.1152\/ajprenal.2001.281.1.F163","article-title":"Downregulation of AQP1, -2, and -3 after ureteral obstruction is associated with a long-term urine-concentrating defect","volume":"281","author":"Li","year":"2001","journal-title":"American journal of physiology. Renal physiology"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0270","first-page":"R1247","article-title":"Impairment of osmotically stimulated AVP release in patients with primary polydipsia","volume":"265","author":"Moses","year":"1993","journal-title":"Am J Physiol"},{"issue":"26","key":"10.1016\/j.cca.2022.02.002_b0275","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJM198112243052601","article-title":"A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria","volume":"305","author":"Zerbe","year":"1981","journal-title":"The New England journal of medicine"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0280","first-page":"471","article-title":"Disorders of body water homeostasis, Best practice & research","volume":"17","author":"Verbalis","year":"2003","journal-title":"Clinical endocrinology & metabolism"},{"issue":"2","key":"10.1016\/j.cca.2022.02.002_b0285","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1530\/EC-14-0113","article-title":"The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsia","volume":"4","author":"de Fost","year":"2015","journal-title":"Endocr Connect"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0290","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1210\/jc.2014-4507","article-title":"Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study","volume":"100","author":"Timper","year":"2015","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"5","key":"10.1016\/j.cca.2022.02.002_b0295","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1803760","article-title":"A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus","volume":"379","author":"Fenske","year":"2018","journal-title":"N Engl J Med"},{"issue":"10198","key":"10.1016\/j.cca.2022.02.002_b0300","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(19)31255-3","article-title":"Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study","volume":"394","author":"Winzeler","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cca.2022.02.002_b0305","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/cen.14417","article-title":"Copeptin is increased by nausea and vomiting during hypertonic saline infusion in healthy individuals","volume":"94","author":"Brooks","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0310","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/EJE-14-0719","article-title":"Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study","volume":"172","author":"Behan","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0315","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1172\/JCI114804","article-title":"Hyponatremia in rats induces downregulation of vasopressin synthesis","volume":"86","author":"Robinson","year":"1990","journal-title":"J Clin Invest"},{"issue":"10198","key":"10.1016\/j.cca.2022.02.002_b0320","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0140-6736(19)31414-X","article-title":"Testing the waters: a new test for hypotonic polyuria","volume":"394","author":"Hoorn","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"26","key":"10.1016\/j.cca.2022.02.002_b0325","first-page":"1434","article-title":"Arginine-initiated release of human growth hormone","volume":"280","author":"Merimee","year":"1969","journal-title":"Factors modifying the response in normal man, The New England journal of medicine"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0330","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11102-012-0453-1","article-title":"Post-operative diabetes insipidus after endoscopic transsphenoidal surgery","volume":"16","author":"Schreckinger","year":"2013","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.cca.2022.02.002_b0335","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/neuros\/nyaa148","article-title":"Diabetes Insipidus After Endoscopic Transsphenoidal Surgery","volume":"87","author":"Burke","year":"2020","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0340","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/alr.22540","article-title":"Predicting prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenoma","volume":"10","author":"Vimawala","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.cca.2022.02.002_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2021.102167","article-title":"Role of copeptin in the diagnosis of traumatic neuroendocrine dysfunction","volume":"89","author":"S\u0103c\u0103rescu","year":"2021","journal-title":"Neuropeptides"},{"issue":"7","key":"10.1016\/j.cca.2022.02.002_b0350","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2006-2046","article-title":"Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay","volume":"92","author":"Katan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0355","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1210\/jc.2014-4527","article-title":"Postoperative Copeptin Concentration Predicts Diabetes Insipidus After Pituitary Surgery","volume":"100","author":"Winzeler","year":"2015","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0360","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1159\/000503145","article-title":"Early Copeptin Determination Allows Prompt Diagnosis of Post-Neurosurgical Central Diabetes Insipidus","volume":"110","author":"Berton","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0365","doi-asserted-by":"crossref","first-page":"17240","DOI":"10.1038\/s41598-021-95500-x","article-title":"Changes in copeptin levels before and 3 months after transsphenoidal surgery according to the presence of postoperative central diabetes insipidus","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.cca.2022.02.002_b0370","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.eprac.2020.11.015","article-title":"Postoperative Copeptin as a Biomarker for Development of Diabetes Insipidus Following Hypothalamic-Pituitary Surgery","volume":"27","author":"Vanasuntorn","year":"2021","journal-title":"Endocr Pract"},{"issue":"10","key":"10.1016\/j.cca.2022.02.002_b0375","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s40618-021-01530-7","article-title":"Usefulness of non-stimulated copeptin in the diagnosis of diabetes insipidus after pituitary surgery","volume":"44","author":"Ferrante","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0380","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/cen.14620","article-title":"Copeptin assays in children for the differential diagnosis of polyuria-polydipsia syndrome and reference levels in hospitalized children","volume":"96","author":"Bonnet","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"21","key":"10.1016\/j.cca.2022.02.002_b0385","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Adrogu\u00e9","year":"2000","journal-title":"The New England journal of medicine"},{"issue":"5","key":"10.1016\/j.cca.2022.02.002_b0390","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0002-9343(67)90096-4","article-title":"The syndrome of inappropriate secretion of antidiuretic hormone","volume":"42","author":"Bartter","year":"1967","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0395","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/jc.2008-1426","article-title":"Copeptin in the differential diagnosis of hyponatremia","volume":"94","author":"Fenske","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.cca.2022.02.002_b0400","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.beem.2016.02.013","article-title":"A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis","volume":"30","author":"Fenske","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0405","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1530\/EC-19-0431","article-title":"Copeptin is not useful as a marker of malignant disease in the syndrome of inappropriate antidiuresis","volume":"9","author":"Winzeler","year":"2020","journal-title":"Endocrine connections"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0410","doi-asserted-by":"crossref","first-page":"371","DOI":"10.23876\/j.krcp.20.233","article-title":"Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study","volume":"40","author":"Go","year":"2021","journal-title":"Kidney Res Clin Pract"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0415","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/cen.13243","article-title":"Evaluation of copeptin and commonly used laboratory parameters for the differential diagnosis of profound hyponatraemia in hospitalized patients: 'The Co-MED Study'","volume":"86","author":"Nigro","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0420","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev.me.31.020180.001531","article-title":"Vasopressin function in the syndrome of inappropriate antidiuresis","volume":"31","author":"Zerbe","year":"1980","journal-title":"Annu Rev Med"},{"issue":"10","key":"10.1016\/j.cca.2022.02.002_b0425","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1681\/ASN.2013080895","article-title":"A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis","volume":"25","author":"Fenske","year":"2014","journal-title":"Journal of the American Society of Nephrology : JASN"},{"issue":"11","key":"10.1016\/j.cca.2022.02.002_b0430","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM196309122691102","article-title":"Carcinoma of the lung with inappropriate antidiuresis. demonstration of antidiuretic-hormone-like activity in tumor extract","volume":"269","author":"Amatruda","year":"1963","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.cca.2022.02.002_b0435","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00392-011-0343-y","article-title":"Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction","volume":"100","author":"Gu","year":"2011","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0440","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2009.01.076","article-title":"Incremental value of copeptin for rapid rule out of acute myocardial infarction","volume":"54","author":"Reichlin","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0445","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3343\/alm.2020.40.1.7","article-title":"Performance of Copeptin for Early Diagnosis of Acute Myocardial Infarction in an Emergency Department Setting","volume":"40","author":"Jeong","year":"2020","journal-title":"Ann Lab Med"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0450","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehu178","article-title":"Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study","volume":"36","author":"Mockel","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0455","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1186\/s13063-018-2990-z","volume":"19","author":"Pedersen","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.cca.2022.02.002_b0460","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijcard.2018.10.084","article-title":"Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction","volume":"276","author":"Mueller-Hennessen","year":"2019","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.cca.2022.02.002_b0465","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.amjcard.2014.01.436","article-title":"A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction","volume":"113","author":"Lipinski","year":"2014","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0470","first-page":"18","article-title":"Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis","volume":"3","author":"Raskovalova","year":"2014","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cca.2022.02.002_b0475","doi-asserted-by":"crossref","unstructured":"M. Roffi, C. Patrono, J.P. Collet, C. Mueller, M. Valgimigli, F. Andreotti, J.J. Bax, M.A. Borger, C. Brotons, D.P. Chew, B. Gencer, G. Hasenfuss, K. Kjeldsen, P. Lancellotti, U. Landmesser, J. Mehilli, D. Mukherjee, R.F. Storey, S. Windecker, E.S.C.S.D. Group, 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC), Eur Heart J 37(3) (2016) 267-315.","DOI":"10.1093\/eurheartj\/ehv320"},{"issue":"16","key":"10.1016\/j.cca.2022.02.002_b0480","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/CIRCULATIONAHA.120.046682","article-title":"Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction","volume":"142","author":"Horiuchi","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cca.2022.02.002_b0485","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jacc.2021.06.027","article-title":"A Biomarker Model to Distinguish Types of Myocardial Infarction and Injury","volume":"78","author":"Neumann","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.cca.2022.02.002_b0490","doi-asserted-by":"crossref","first-page":"e0238288","DOI":"10.1371\/journal.pone.0238288","article-title":"Prognostic value of copeptin in patients with acute coronary syndrome: A systematic review and meta-analysis","volume":"15","author":"Lu","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2022.02.002_b0495","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2015.04.133","article-title":"Incremental value of copeptin to highly sensitive cardiac Troponin I for rapid rule-out of myocardial infarction","volume":"190","author":"Wildi","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.cca.2022.02.002_b0500","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/1354750X.2020.1833084","article-title":"Copeptin combined with either non-high sensitivity or high sensitivity cardiac troponin for instant rule-out of suspected non-ST segment elevation myocardial infarction","volume":"25","author":"Giannitsis","year":"2020","journal-title":"Biomarkers"},{"issue":"2","key":"10.1016\/j.cca.2022.02.002_b0505","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/SHK.0b013e318033e5da","article-title":"Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock","volume":"28","author":"Morgenthaler","year":"2007","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0510","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/cc9102","article-title":"Proven infection-related sepsis induces a differential stress response early after ICU admission","volume":"14","author":"Lesur","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.cca.2022.02.002_b0515","doi-asserted-by":"crossref","first-page":"3624730","DOI":"10.1155\/2016\/3624730","article-title":"Assessment of Diagnostic and Prognostic Role of Copeptin in the Clinical Setting of Sepsis","volume":"2016","author":"Battista","year":"2016","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0520","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00134-019-05912-7","article-title":"Renin aldosterone vasopressin and copeptin kinetics in patients with septic shock, a post-hoc Hyper2S randomized trial analysis","volume":"46","author":"Olivier","year":"2020","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.cca.2022.02.002_b0525","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.rmed.2012.06.008","article-title":"Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia","volume":"106","author":"Kolditz","year":"2012","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.cca.2022.02.002_b0530","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.19082\/4880","article-title":"Predictive value of copeptin as a severity marker of community-acquired pneumonia","volume":"9","author":"Mohamed","year":"2017","journal-title":"Electron Physician"},{"issue":"3","key":"10.1016\/j.cca.2022.02.002_b0535","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jinf.2016.01.002","article-title":"Biomarkers for predicting short-term mortality in community-acquired pneumonia: A systematic review and meta-analysis","volume":"72","author":"Viasus","year":"2016","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0540","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI105504","article-title":"Increased plasma arginine vasopressin in clinical adrenocortical insufficeincy and its inhibition by glucosteroids","volume":"46","author":"Ahmed","year":"1967","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.cca.2022.02.002_b0545","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/jim-2018-000886","article-title":"Copeptin levels upon corticosteroid treatment in acute community-acquired pneumonia","volume":"67","author":"Popovic","year":"2019","journal-title":"J Investig Med"},{"key":"10.1016\/j.cca.2022.02.002_b0550","doi-asserted-by":"crossref","first-page":"11665","DOI":"10.1038\/srep11665","article-title":"Prognostic role of copeptin after stroke: A systematic review and meta-analysis of observational studies","volume":"5","author":"Choi","year":"2015","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.cca.2022.02.002_b0555","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/hr.2016.165","article-title":"Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis","volume":"40","author":"Xu","year":"2017","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cca.2022.02.002_b0560","article-title":"Biomarkers Predictive of Long-Term Outcome After Ischemic Stroke: A Meta-Analysis","author":"Soldozy","year":"2021","journal-title":"World Neurosurg"},{"issue":"13","key":"10.1016\/j.cca.2022.02.002_b0565","doi-asserted-by":"crossref","first-page":"e1517","DOI":"10.1212\/WNL.0000000000007177","article-title":"A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score","volume":"92","author":"De Marchis","year":"2019","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.cca.2022.02.002_b0570","first-page":"2387","article-title":"Copeptin Levels in Cerebral Infarction, Intracranial Hemorrhage and Subarachnoid Hemorrhage","volume":"62","author":"Aksu","year":"2016","journal-title":"Clin Lab"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0575","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12035-015-9626-z","article-title":"Association Between Circulating Copeptin Level and Mortality Risk in Patients with Intracerebral Hemorrhage: a Systemic Review and Meta-Analysis","volume":"54","author":"Zhang","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.cca.2022.02.002_b0580","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.acc.2015.10.006","article-title":"Copeptin in Heart Failure","volume":"73","author":"Balling","year":"2016","journal-title":"Adv. Clin. Chem."},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0585","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00059-018-4702-6","article-title":"Diagnostic value of novel biomarkers for heart failure : A meta-analysis","volume":"45","author":"Huang","year":"2020","journal-title":"Herz"},{"issue":"39","key":"10.1016\/j.cca.2022.02.002_b0590","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012610","article-title":"The clinical application value of the plasma copeptin level in the assessment of heart failure with reduced left ventricular ejection fraction: A cross-sectional study","volume":"97","author":"Xu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2022.02.002_b0595","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/TCRM.S124689","article-title":"Prognostic role of copeptin with all-cause mortality after heart failure: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"10.1016\/j.cca.2022.02.002_b0600","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/jcmm.13102","article-title":"Predictive value of plasma copeptin level for the risk and mortality of heart failure: a meta-analysis","volume":"21","author":"Yan","year":"2017","journal-title":"J Cell Mol Med"},{"issue":"20","key":"10.1016\/j.cca.2022.02.002_b0605","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.2011.666","article-title":"Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure","volume":"305","author":"Alehagen","year":"2011","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.cca.2022.02.002_b0610","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/WNL.0000000000003937","article-title":"Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke","volume":"88","author":"Tu","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.cca.2022.02.002_b0615","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MAJ.0b013e31829a63b1","article-title":"The value of assessment tests in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"347","author":"Zhao","year":"2014","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0620","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12931-017-0665-z","article-title":"Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study","volume":"18","author":"Winther","year":"2017","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0625","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1183\/13993003.01485-2015","article-title":"Prognostic assessment in COPD without lung function: the B-AE-D indices","volume":"47","author":"Boeck","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cca.2022.02.002_b0630","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2147\/COPD.S126400","article-title":"Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study","volume":"12","author":"Dres","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"19","key":"10.1016\/j.cca.2022.02.002_b0635","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/CIRCULATIONAHA.109.909663","article-title":"Plasma copeptin and the risk of diabetes mellitus","volume":"121","author":"Enh\u00f6rning","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2022.02.002_b0640","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12933-018-0753-5","article-title":"Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes","volume":"17","author":"Velho","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.cca.2022.02.002_b0645","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.2337\/dc19-1062","article-title":"Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes","volume":"42","author":"Potier","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.cca.2022.02.002_b0650","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/liv.12428","article-title":"Cardiac and proinflammatory markers predict prognosis in cirrhosis","volume":"34","author":"Wiese","year":"2014","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.cca.2022.02.002_b0655","doi-asserted-by":"crossref","first-page":"e0138264","DOI":"10.1371\/journal.pone.0138264","article-title":"Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis","volume":"10","author":"Kerbert","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0660","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/liv.12992","article-title":"Copeptin is an independent prognostic factor for transplant-free survival in cirrhosis","volume":"36","author":"Kerbert","year":"2016","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cca.2022.02.002_b0665","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jhep.2016.07.003","article-title":"Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis","volume":"65","author":"Sol\u00e0","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cca.2022.02.002_b0670","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/jgh.15215","article-title":"Serum copeptin level is a biomarker associated with ascites retention and the formation of a portosystemic shunt in chronic liver disease","volume":"36","author":"Shigefuku","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"21","key":"10.1016\/j.cca.2022.02.002_b0675","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.2169\/internalmedicine.7291-21","article-title":"Serum Copeptin and Zinc-\u03b12-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites","volume":"60","author":"Shigefuku","year":"2021","journal-title":"Intern Med"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:02:48Z","timestamp":1757862168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":135,"alternative-id":["S0009898122000456"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.02.002","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copeptin in fluid disorders and stress","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}